BIOMAT Database Logo BIOMAT Database Logo

The CREST syndrome--successful reduction of pulmonary hypertension by captopril. 1984

P J Prouse, and A Lahiri, and J M Gumpel

A patient with severe pulmonary hypertension due to pulmonary arteriolar obliteration complicating a long standing CREST variant of systemic sclerosis showed improvement in cardiac output and exercise tolerance during treatment with captopril, which was discontinued because of persistent systemic hypotension. It is suggested that captopril would have a useful and possible prophylactic effect early in pulmonary hypertension in systemic sclerosis.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

P J Prouse, and A Lahiri, and J M Gumpel
[CREST syndrome presenting as pulmonary hypertension].
February 1999, Annales de cardiologie et d'angeiologie,
P J Prouse, and A Lahiri, and J M Gumpel
CREST syndrome with pulmonary arterial hypertension.
January 2012, Internal medicine (Tokyo, Japan),
P J Prouse, and A Lahiri, and J M Gumpel
[Pulmonary hypertension in diffuse scleroderma and the CREST syndrome].
January 1989, Plucne bolesti : casopis Udruzenja pneumoftiziologa Jugoslavije = the journal of Yugoslav Association of Phthisiology and Pneumology,
P J Prouse, and A Lahiri, and J M Gumpel
[CREST syndrome and pulmonary hypertension: a dark prognosis].
January 2004, Acta medica portuguesa,
P J Prouse, and A Lahiri, and J M Gumpel
Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
October 2001, The Journal of rheumatology,
P J Prouse, and A Lahiri, and J M Gumpel
Pulmonary hypertension with limited cutaneous scleroderma (CREST syndrome).
December 2000, The Netherlands journal of medicine,
P J Prouse, and A Lahiri, and J M Gumpel
Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis.
April 1986, Arthritis and rheumatism,
P J Prouse, and A Lahiri, and J M Gumpel
[The cold test in the CREST syndrome with pulmonary hypertension].
May 1986, Presse medicale (Paris, France : 1983),
P J Prouse, and A Lahiri, and J M Gumpel
Captopril in pulmonary hypertension.
May 1983, British heart journal,
P J Prouse, and A Lahiri, and J M Gumpel
[Severe isolated pulmonary hypertension as main manifestation of Crest syndrome].
July 2000, Anales de medicina interna (Madrid, Spain : 1984),
Copied contents to your clipboard!